Papakyriakopoulou P, Valsami G, Dev K
Mol Neurobiol. 2024; 61(11):8688-8701.
PMID: 38558359
PMC: 11496341.
DOI: 10.1007/s12035-024-04137-0.
Maghazachi A
Immunotargets Ther. 2023; 12:105-111.
PMID: 37928748
PMC: 10625317.
DOI: 10.2147/ITT.S424622.
Herdt A, Peng H, Dickson D, Golde T, Eckman E, Lee C
Genes (Basel). 2023; 14(8).
PMID: 37628569
PMC: 10454254.
DOI: 10.3390/genes14081517.
Braz S, Morgado M, Pereira M, Monteiro A, Golonzhka O, Jarpe M
Front Mol Neurosci. 2023; 16:1231659.
PMID: 37588057
PMC: 10426153.
DOI: 10.3389/fnmol.2023.1231659.
Kreher C, Favret J, Weinstock N, Maulik M, Hong X, Gelb M
PLoS Biol. 2022; 20(7):e3001661.
PMID: 35789331
PMC: 9255775.
DOI: 10.1371/journal.pbio.3001661.
Chronic lithium administration in a mouse model for Krabbe disease.
Del Grosso A, Parlanti G, Angella L, Giordano N, Tonazzini I, Ottalagana E
JIMD Rep. 2022; 63(1):50-65.
PMID: 35028271
PMC: 8743347.
DOI: 10.1002/jmd2.12258.
Can early treatment of twitcher mice with high dose AAVrh10-GALC eliminate the need for BMT?.
Rafi M, Luzi P, Wenger D
Bioimpacts. 2021; 11(2):135-146.
PMID: 33842284
PMC: 8022232.
DOI: 10.34172/bi.2021.21.
Neuropathophysiology of Lysosomal Storage Diseases: Synaptic Dysfunction as a Starting Point for Disease Progression.
Para C, Bose P, Pshezhetsky A
J Clin Med. 2020; 9(3).
PMID: 32106459
PMC: 7141115.
DOI: 10.3390/jcm9030616.
Unfolded protein response is activated in Krabbe disease in a manner dependent on the mutation type.
Irahara-Miyana K, Otomo T, Kondo H, Hossain M, Ozono K, Sakai N
J Hum Genet. 2018; 63(6):699-706.
PMID: 29615819
DOI: 10.1038/s10038-018-0445-8.
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease.
Cappello V, Marchetti L, Parlanti P, Landi S, Tonazzini I, Cecchini M
Sci Rep. 2017; 6(1):1.
PMID: 28442746
PMC: 5431369.
DOI: 10.1038/s41598-016-0001-8.
Krabbe Disease: Report of a Rare Lipid Storage and Neurodegenerative Disorder.
Pavuluri P, Vadakedath S, Gundu R, Uppulety S, Kandi V
Cureus. 2017; 9(1):e949.
PMID: 28168127
PMC: 5289898.
DOI: 10.7759/cureus.949.
Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.
Won J, Singh A, Singh I
J Neurosci Res. 2016; 94(11):990-1006.
PMID: 27638584
PMC: 5812347.
DOI: 10.1002/jnr.23873.
Generation of a LacZ reporter transgenic mouse line for the stereological analysis of oligodendrocyte loss in galactosylceramidase deficiency.
Zhu H, Ornaghi F, Belin S, Givogri M, Wrabetz L, Bongarzone E
J Neurosci Res. 2016; 94(12):1520-1530.
PMID: 27426866
PMC: 5069144.
DOI: 10.1002/jnr.23839.
DNA promoter hypermethylation contributes to down-regulation of galactocerebrosidase gene in lung and head and neck cancers.
Peng J, Chen B, Shen Z, Deng H, Liu D, Xie X
Int J Clin Exp Pathol. 2015; 8(9):11042-50.
PMID: 26617822
PMC: 4637637.
Mechanism of neuromuscular dysfunction in Krabbe disease.
Cantuti-Castelvetri L, Maravilla E, Marshall M, Tamayo T, dAuria L, Monge J
J Neurosci. 2015; 35(4):1606-16.
PMID: 25632136
PMC: 4308604.
DOI: 10.1523/JNEUROSCI.2431-14.2015.
GC-EI-MS analysis of fatty acid composition in brain and serum of twitcher mouse.
Zanfini A, Dreassi E, Berardi A, Piomboni P, Costantino-Ceccarini E, Luddi A
Lipids. 2014; 49(11):1115-25.
PMID: 25208498
DOI: 10.1007/s11745-014-3945-0.
Early axonal loss accompanied by impaired endocytosis, abnormal axonal transport, and decreased microtubule stability occur in the model of Krabbe's disease.
Teixeira C, Miranda C, Sousa V, Santos T, Malheiro A, Solomon M
Neurobiol Dis. 2014; 66:92-103.
PMID: 24607884
PMC: 4307018.
DOI: 10.1016/j.nbd.2014.02.012.
Structural snapshots illustrate the catalytic cycle of β-galactocerebrosidase, the defective enzyme in Krabbe disease.
Hill C, Graham S, Read R, Deane J
Proc Natl Acad Sci U S A. 2013; 110(51):20479-84.
PMID: 24297913
PMC: 3870757.
DOI: 10.1073/pnas.1311990110.
Missense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe disease.
Potter G, Santos M, Davisson M, Rowitch D, Marks D, Bongarzone E
Hum Mol Genet. 2013; 22(17):3397-414.
PMID: 23620143
PMC: 3736866.
DOI: 10.1093/hmg/ddt190.
On the role of natural killer cells in neurodegenerative diseases.
Maghazachi A
Toxins (Basel). 2013; 5(2):363-75.
PMID: 23430541
PMC: 3640540.
DOI: 10.3390/toxins5020363.